Loading...
| A11843 | Pages: 134 | Jun 2021 | 262 Views | | |
| Author(s) : VISHAL BHARDWAJ, LINU DASH , ONKAR SUMANT | Tables: 32 | Charts: 49 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the India Pharmaceutical Packaging Market
Request Now !The India pharmaceutical packaging market size was valued at $1434.1 million in 2020, and is projected to reach $3027.14 million by 2030 at a CAGR of 7.54% from 2021 to 2030.
"The spread of COVID-19 pandemic is significantly propelling the demand of pharmaceutical packaging in order to develop more medicines to support the treatment of current ongoing COVID-19 pandemic Moreover, due to post covid complications and rise in case of infections there has been sudden rise in sterile packaging which boosted the Indian pharmaceutical packaging market."
Packaging plays a crucial role in the pharma industry, where its function extends beyond serving as a branding aid and providing barrier protection to products for the shelf-life period. It is increasingly playing a vital role in ensuring overall patient safety by carrying key information pertaining to the product, ensuring tamper-evidence, and traceability of products. Pharmaceutical packaging is usually the economic means of providing presentation, protection, identification, information, convenience, integrity, and stability of the product.
Get more information on this report : Request Sample Pages
India is the second most populated country with 1.34 billion people and is the third-largest economy. Despite significant improvements in healthcare in the past years, there has been an increase in the number of chronic disease cases at a rapid pace. India is the third-largest producer of pharmaceuticals in terms of volume and thirteenth most significant in terms of value as it has a large raw material base and availability of a skilled workforce. The country offers one of the lowest manufacturing costs in the world, more economical than that of the U.S. and almost half of Europe, and is the largest supplier of generic medicines in the world (20% to 22% of global export volume). It has fuelled the research and development of efficient packing solutions for the pharmaceutical sector that substantially prevents contamination, provides drug safety, and convenience of delivery and handling. Pharmaceutical companies are relying more on packaging and labelling as media to promote and protect their products in the increasing counterfeit market and to meet the new safety regulations.
The specific needs of the elderly and handicapped are being integrated into packaging design, thus making the product more convenient to use. Brand protection to prevent counterfeiting is also a significant factor that enhances competition in the market. The development of new packaging types such as child-resistant packaging (CRP), radiofrequency identification technology, and others with improved properties have led to the rapid growth of the India pharmaceutical packaging market. The adoption and compliance with regulatory norms in pharmaceutical packaging, along with standards about packaging recycling, also fuels the growth of the India pharmaceutical packaging market.
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. Nationwide lockdown, government regulations, and continuous increase in infection rate across the country created a widespread financial impact on packaging market. Due to lockdown in the entire region the company’s manufacturing bags, bottles, ampoules, cartridges, and couldn’t supply the products to pharma companies logistically. COVID-19 has created demand for sterile packaging in market as it has created fear among consumers about ability of virus to stay alive in packaging surfaces, this has created opportunity between key players to meet demands of market. But the Indian government has partly lifted the restriction to export for two drugs, hydroxychloroquine (HCQ), an anti-malarial drug considered suitable for the treatment of COVID-19, and paracetamol. This has again increased the demand for better pharmaceutical secondary and tertiary packaging market in India.
Get more information on this report : Request Sample Pages
The India pharmaceutical packaging market is segmented into product and material. On the basis of product, the market is bifurcated into specialty bags, parenteral container and others. The specialty bags are further segmented urinary collection bags, bile collection bags, blood bags, sterile packaging bags, and enteral feeding. Further, parenteral container is split into bags, bottles, ampoules, vials, cartridges and others. The material segment is further divided into glass, aluminum foils, plastics and polymers, paper and paperboards and others.
Plastics and polymers segment is anticipated to experience significant growth and is expect to lead the India pharmaceutical packaging market. Plastics and polymers packaging has gained popularity due to its properties such as barrier against moisture, high dimensional stability, high impact strength, resistance to strain, low water absorption, transparency, and resistance to heat and flame. Bottles used for pharma packaging are made of a variety of plastic such as polyvinyl chloride, polyethylene, polypropylene, and polystyrene. It is a clear, strong, and lightweight plastic that is also used for storing and selling packaged products across the industry, such as drinking water, carbonated soft drinks, and soda. They are mostly used as primary and secondary packaging material.
Get more information on this report : Request Sample Pages
India has one of the lowest manufacturing costs in the world, more economical than that of the U.S. and almost half of Europe. It is the largest supplier of generic medicines in the world (20% to 22% of global export volume). It has fuelled the research and development of efficient packing solutions for the pharmaceutical sector that substantially prevents contamination, provides drug safety, and convenience of delivery and handling.
Moreover, India imports 70% of APIs from China and to safeguard the country. On March 3, 2020, India has restricted the export of 26 active pharmaceutical ingredients (API) and medicines due to the impact of coronavirus COVID-19 in China, that accounts 10% of all exports from the country. This has caused a panic in European countries as 26% of the European formulations are controlled by Indian APIs. But the Indian government has partly lifted the restriction to export for two drugs, hydroxychloroquine (HCQ), an anti-malarial drug considered suitable for the treatment of COVID-19, and paracetamol. This has again increased the demand for better pharmaceutical secondary and tertiary packaging market in India.
List Of Key Companies:
Key Benefits For Stakeholders
Key Market Segments
By Product
By Material Type
CHAPTER 1: INTRODUCTION
1.1. Report description
1.1.1. Key benefits for stakeholders
1.1.2. Key market segments
1.1.3. List of key players profiled in the report
1.2. Research methodology
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top player positioning, 2020
3.4. Porter’s five forces analysis
3.5. Impact analysis of COVID-19 on the pharmaceutical packaging market
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Advanced manufacturing processes to develop sustainable and eco-friendly packaging solutions
3.6.1.2. Increase in product innovations and merger & acquisition to support new demands
3.6.1.3. Emerging generic drug market and rapidly growing drug delivery market
3.6.1.4. Increase in R&D and use of innovative packaging
3.6.2. Restraints
3.6.2.1. Price volatility of raw materials
3.6.2.2. Stringent government regulations and standards
3.6.3. Opportunities
3.6.3.1. Advancement in the biotechnology sector results in the introduction of new parenteral therapies and demand for innovative packaging products
3.6.3.2. Growth in use of the smart packaging for patient engagement and identification
3.6.3.3. Increase in a patient-oriented medicines including biologics
3.6.4. Impact analysis
CHAPTER 4: PHARMACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Specialty Bags
4.2.1. Key growth factors and opportunities
4.2.2. Product Type, By Specialty Bags
4.2.2.1. Market size and forecast
4.2.2.2. Urinary Collection Bags
4.2.2.2.1. Market size and forecast
4.2.2.3. Bile Collection Bags
4.2.2.3.1. Market size and forecast
4.2.2.4. Blood Bags
4.2.2.4.1. Market size and forecast
4.2.2.5. Sterile Packaging Bags
4.2.2.5.1. Market size and forecast
4.2.2.6. Enteral Feeding
4.2.2.6.1. Market size and forecast
4.3. Parenteral container
4.3.1. Key market trends and opportunities
4.3.2. Product Type, By Parenteral Container
4.3.2.1. Market size and forecast
4.3.2.2. Bags
4.3.2.2.1. Market size and forecast
4.3.2.3. Bottles
4.3.2.3.1. Market size and forecast
4.3.2.4. Ampoules
4.3.2.4.1. Market size and forecast
4.3.2.5. Vials
4.3.2.5.1. Market size and forecast
4.3.2.6. Cartridges
4.3.2.6.1. Market size and forecast
4.3.2.7. Others
4.3.2.7.1. Market size and forecast
4.4. Others
4.4.1. Key market trends and opportunities
CHAPTER 5: PHARMACEUTICAL PACKAGING MARKET, BY MATERIAL
5.1. Overview
5.1.1. Market size and forecast
5.2. Glass
5.2.1. Key growth factors and opportunities
5.2.2. Market size and forecast
5.3. Aluminum foils
5.3.1. Key growth factors and opportunities
5.3.2. Market size and forecast
5.4. Plastics and polymers
5.4.1. Key growth factors and opportunities
5.4.2. Market size and forecast
5.5. Paper & paperboards
5.5.1. Key growth factors and opportunities
5.5.2. Market size and forecast
5.6. Others
5.6.1. Key growth factors and opportunities
5.6.2. Market size and forecast
CHAPTER 6: COMPANY PROFILES
6.1. Amcor Plc.
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments
6.2. Aptar Group Inc.
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product Portfolio
6.2.5. Business performance
6.2.6. Key strategic moves and developments
6.3. ESSEL PROPACK LIMITED.
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product Portfolio
6.3.5. Business performance
6.3.6. Key strategic moves and developments
6.4. Huhtamaki plc.
6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Product Portfolio
6.4.5. Business performance
6.4.6. Key strategic moves and developments
6.5. Nipro Corporation
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance
6.6. Parekhplast plc.
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product portfolio
6.7. SCHOTT AG
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance
6.8. SGD PHARMA INDIA LIMITED.
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Business performance
6.9. UFLEX LIMITED
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance
6.9.6. Key strategic moves and developments
6.10. WEST Pharmaceutical Services INC.
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product portfolio
6.10.5. Business performance
6.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. INDIA PHARMACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 02. INDIA PHARMACEUTICAL PACKAGING MARKET, BY SPECIALITY BAGS , 2020-2030 ($MILLION)
TABLE 03. INDIA PHARMACEUTICAL PACKAGING MARKET, BY PARENTERAL CONTAINER, 2020-2030 ($MILLION)
TABLE 04. INDIA PHARMACEUTICAL PACKAGING MARKET, BY MATERIAL, 2020-2030 ($MILLION)
TABLE 05. AMCOR: COMPANY SNAPSHOT
TABLE 06. AMCOR: OPERATING SEGMENTS
TABLE 07. AMCOR: PRODUCT PORTFOLIO
TABLE 08. APTAR: COMPANY SNAPSHOT
TABLE 09. APTAR: OPERATING SEGMENTS
TABLE 10. APTAR: PRODUCT PORTFOLIO
TABLE 11. EPL: COMPANY SNAPSHOT
TABLE 12. EPL: BUSINESS SEGMENT
TABLE 13. HUHTAMAKI: COMPANY SNAPSHOT
TABLE 14. HUHTAMAKI: BUSINESS SEGMENT
TABLE 15. NIPRO: COMPANY SNAPSHOT
TABLE 16. NIPRO: OPERATING SEGMENTS
TABLE 17. NIPRO: PRODUCT PORTFOLIO
TABLE 18. PAREKHPLAST: COMPANY SNAPSHOT
TABLE 19. PAREKHPLAST: OPERATING SEGMENTS
TABLE 20. PAREKHPLAST: PRODUCT PORTFOLIO
TABLE 21. SCHOTT: COMPANY SNAPSHOT
TABLE 22. SCHOTT: OPERATING SEGMENTS
TABLE 23. SCHOTT: PRODUCT PORTFOLIO
TABLE 24. SGD: COMPANY SNAPSHOT
TABLE 25. SGD: OPERATING SEGMENTS
TABLE 26. SGD: PRODUCT PORTFOLIO
TABLE 27. ULFEX: COMPANY SNAPSHOT
TABLE 28. ULFEX: OPERATING SEGMENTS
TABLE 29. ULFEX: PRODUCT PORTFOLIO
TABLE 30. WEST: COMPANY SNAPSHOT
TABLE 31. WEST: OPERATING SEGMENTS
TABLE 32. WEST: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. INDIA PHARMACEUTICAL PACKAGING MARKETSEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018–2021*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018–2021* (%)
FIGURE 06. TOP PLAYER POSITIONING, 2020
FIGURE 07. HIGH BARGAINING POWER OF BUYERS
FIGURE 08. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE THREAT OF SUBSTITUTION
FIGURE 11. MODERATE COMPETITIVE RIVALRY
FIGURE 12. IMPACT ANALYSIS:
FIGURE 13. INDIA PHARMACEUTICAL PACKAGING MARKET,BY URINARY COLLECTION BAGS 2020–2030 ($MILLION)
FIGURE 14. INDIA PHARMACEUTICAL PACKAGING MARKET, BY BILE COLLECTION BAGS 2020–2030 ($MILLION)
FIGURE 15. INDIA PHARMACEUTICAL PACKAGING MARKET, BY BLOOD BAGS 2020–2030 ($MILLION)
FIGURE 16. INDIA PHARMACEUTICAL PACKAGING MARKET, BY STERILE PACKAGING BAGS 2020–2030, ($MILLION)
FIGURE 17. INDIA PHARMACEUTICAL PACKAGING MARKET, BY ENTERAL FEEDING, 2020–2030 ($MILLION)
FIGURE 18. INDIA PHARMACEUTICAL PACKAGING MARKET, BY BAGS, 2020–2030 ($MILLION)
FIGURE 19. INDIA PHARMACEUTICAL PACKAGING MARKET , BY BOTTLES, 2020–2030 ($MILLION)
FIGURE 20. INDIA PHARMACEUTICAL PACKAGING MARKET, BY AMPOULES 2020–2030 ($MILLION)
FIGURE 21. INDIA PHARMACEUTICAL PACKAGING MARKET, BY VIALS 2020–2030 ($MILLION)
FIGURE 22. INDIA PHARMACEUTICAL PACKAGING MARKET, BY CARTRIDGES 2020–2030 ($MILLION)
FIGURE 23. INDIA PHARMACEUTICAL PACKAGING MARKET, BY OTHERS 2020–2030 ($MILLION)
FIGURE 24. INDIA PHARMACEUTICAL PACKAGING MARKET, BY GLASS, 2020–2030 ($MILLION)
FIGURE 25. INDIA PHARMACEUTICAL PACKAGING MARKET, BY ALUMINUM FOILS 2020–2030 ($MILLION)
FIGURE 26. INDIA PHARMACEUTICAL PACKAGING MARKET, BY PLASTICS AND POLYMERS 2020–2030 ($MILLION)
FIGURE 27. INDIA PHARMACEUTICAL PACKAGING MARKET, BY PAPER AND PAPERBOARDS, 2020–2030 ($MILLION)
FIGURE 28. INDIA PHARMACEUTICAL PACKAGING MARKET, BY OTHERS, 2020–2030 ($MILLION)
FIGURE 29. AMCOR: NET SALES, 2018–2020 ($MILLION)
FIGURE 30. AMCOR: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31. AMCOR: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 32. NET SALES, 2018–2020 ($MILLION)
FIGURE 33. APTAR: NET SALES BY DIVISION, 2020 (%)
FIGURE 34. APTAR: NET SALES BY REGION, 2020 (%)
FIGURE 35. NET SALES, 2018–2020 ($MILLION)
FIGURE 36. NET SALES, 2018–2020 ($MILLION)
FIGURE 37. HUHTAMAKI: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38. NET SALES, 2018–2020 ($MILLION)
FIGURE 39. NIPRO REVENUE SHARE BY BUSINESS UNIT, 2020 (%)
FIGURE 40. NIPRO: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 41. NET SALES, 2017–2019 ($MILLION)
FIGURE 42. SCHOTT: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 43. NET SALES, 2018–2020 ($MILLION)
FIGURE 44. SGD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 45. ULFEX: NET SALES, 2018–2020 ($MILLION)
FIGURE 46. ULFEX: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 47. WEST NET SALES, 2019–2020 ($MILLION)
FIGURE 48. WEST: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 49. WEST: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
The factors that drive the growth of India pharmaceutical packaging market include surge in population, rise in health awareness, and increase in life expectancy can be attributed to the growth of the pharmaceuticals packaging industry. Moreover, rise in awareness of environmental issues due to traditional packaging material and the adoption and compliance with regulatory norms in pharmaceutical packaging, along with standards about packaging recycling is fueling the growth of the market. Poverty, lack of proper infrastructure, low literacy rate, and prevalence of unorganized healthcare systems in the emerging markets limit the growth of the market. However, rising packaging costs owing to stringent regulations and anti-counterfeiting efforts is likely to restrain the market growth.
A. No, there is no value chain analysis provided in the India pharmaceutical packaging Market report
A. The key trends in the India pharmaceutical packaging Market are surge in health awareness, rise in population, increase in life expectancy, and new regulatory standards
A. The total market value of India pharmaceutical packaging Market is $1434.10 million in 2020.
A. The market value of India pharmaceutical packaging Market in 2021 was $3027.14 Million
A. The top companies that hold the market share in India pharmaceutical packaging Market are Amcor Plc., West Pharmaceutical Packaging India Pvt. Ltd., SGD Pharma India Ltd, APTAR GROUP, INC., Uflex Limited, Essel Propack Ltd, and others.
A. The base year for the report is 2020.
A. Yes, India pharmaceutical packaging companies are profiled in the report
A. The forecast period in the report is from 2021 to 2030
Enterprise
License/PDF
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
